Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS PHARMACIE MEDITERRAPHARM : revenue, balance sheet and financial ratios

SELAS PHARMACIE MEDITERRAPHARM is a French company founded 2 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in NICE (06000), this company of category PME shows in 2024 a net income negative of -233 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE MEDITERRAPHARM (SIREN 978113678)
Indicator 2024
Revenue N/C
Net income -233 343 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2024, SELAS PHARMACIE MEDITERRAPHARM records a net loss of 233 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-233 343 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -1718%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -5%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-1718.071%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-4.953%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

96.9%

Solvency indicators evolution
SELAS PHARMACIE MEDITERRAPHARM

Sector positioning

Debt ratio
-1718.07 2024
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent

In 2024, the debt ratio of SELAS PHARMACIE MEDITERRA... (-1718.07) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-4.95% 2024
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of SELAS PHARMACIE MEDITERRA... (-5.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 173.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

173.41

Liquidity indicators evolution
SELAS PHARMACIE MEDITERRAPHARM

Sector positioning

Liquidity ratio
173.41 2024
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average

In 2024, the liquidity ratio of SELAS PHARMACIE MEDITERRA... (173.41) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SELAS PHARMACIE MEDITERRAPHARM in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE MEDITERRAPHARM with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE MEDITERRAPHARM

What is the revenue of SELAS PHARMACIE MEDITERRAPHARM ?

The revenue of SELAS PHARMACIE MEDITERRAPHARM is not publicly disclosed (confidential accounts filed with INPI).

Is SELAS PHARMACIE MEDITERRAPHARM profitable?

SELAS PHARMACIE MEDITERRAPHARM recorded a net loss in 2024.

Where is the headquarters of SELAS PHARMACIE MEDITERRAPHARM ?

The headquarters of SELAS PHARMACIE MEDITERRAPHARM is located in NICE (06000), in the department Alpes-Maritimes.

Where to find the tax return of SELAS PHARMACIE MEDITERRAPHARM ?

The tax return of SELAS PHARMACIE MEDITERRAPHARM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE MEDITERRAPHARM operate?

SELAS PHARMACIE MEDITERRAPHARM operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.